Bronchial thermoplasty in asthma: an exploratory histopathological evaluation in distinct asthma endotypes/phenotypes.

Airway smooth muscle Asthma endotypes Asthma phenotypes Bronchial thermoplasty Epithelial cell regeneration Glucocorticoid receptor Heat shock proteins Severe asthma

Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
28 Jun 2021
Historique:
received: 08 02 2021
accepted: 07 06 2021
entrez: 29 6 2021
pubmed: 30 6 2021
medline: 15 12 2021
Statut: epublish

Résumé

Bronchial thermoplasty regulates structural abnormalities involved in airway narrowing in asthma. In the present study we aimed to investigate the effect of bronchial thermoplasty on histopathological bronchial structures in distinct asthma endotypes/phenotypes. Endobronchial biopsies (n = 450) were collected from 30 patients with severe uncontrolled asthma before bronchial thermoplasty and after 3 sequential bronchial thermoplasties. Patients were classified based on blood eosinophils, atopy, allergy and smoke exposure. Tissue sections were assessed for histopathological parameters and expression of heat-shock proteins and glucocorticoid receptor. Proliferating cells were determined by Ki67-staining. In all patients, bronchial thermoplasty improved asthma control (p < 0.001), reduced airway smooth muscle (p = 0.014) and increased proliferative (Ki67 +) epithelial cells (p = 0.014). After bronchial thermoplasty, airway smooth muscle decreased predominantly in patients with T2 high asthma endotype. Epithelial cell proliferation was increased after bronchial thermoplasty in patients with low blood eosinophils (p = 0.016), patients with no allergy (p = 0.028) and patients without smoke exposure (p = 0.034). In all patients, bronchial thermoplasty increased the expression of glucocorticoid receptor in epithelial cells (p = 0.018) and subepithelial mesenchymal cells (p = 0.033) and the translocation of glucocorticoid receptor in the nucleus (p = 0.036). Furthermore, bronchial thermoplasty increased the expression of heat shock protein-70 (p = 0.002) and heat shock protein-90 (p = 0.001) in epithelial cells and decreased the expression of heat shock protein-70 (p = 0.009) and heat shock protein-90 (p = 0.002) in subepithelial mesenchymal cells. The effect of bronchial thermoplasty on the expression of heat shock proteins -70 and -90 was distinctive across different asthma endotypes/phenotypes. Bronchial thermoplasty leads to a diminishment of airway smooth muscle, to epithelial cell regeneration, increased expression and activation of glucocorticoid receptor in the airways and increased expression of heat shock proteins in the epithelium. Histopathological effects appear to be distinct in different endotypes/phenotypes indicating that the beneficial effects of bronchial thermoplasty are achieved by diverse molecular targets associated with asthma endotypes/phenotypes.

Sections du résumé

BACKGROUND BACKGROUND
Bronchial thermoplasty regulates structural abnormalities involved in airway narrowing in asthma. In the present study we aimed to investigate the effect of bronchial thermoplasty on histopathological bronchial structures in distinct asthma endotypes/phenotypes.
METHODS METHODS
Endobronchial biopsies (n = 450) were collected from 30 patients with severe uncontrolled asthma before bronchial thermoplasty and after 3 sequential bronchial thermoplasties. Patients were classified based on blood eosinophils, atopy, allergy and smoke exposure. Tissue sections were assessed for histopathological parameters and expression of heat-shock proteins and glucocorticoid receptor. Proliferating cells were determined by Ki67-staining.
RESULTS RESULTS
In all patients, bronchial thermoplasty improved asthma control (p < 0.001), reduced airway smooth muscle (p = 0.014) and increased proliferative (Ki67 +) epithelial cells (p = 0.014). After bronchial thermoplasty, airway smooth muscle decreased predominantly in patients with T2 high asthma endotype. Epithelial cell proliferation was increased after bronchial thermoplasty in patients with low blood eosinophils (p = 0.016), patients with no allergy (p = 0.028) and patients without smoke exposure (p = 0.034). In all patients, bronchial thermoplasty increased the expression of glucocorticoid receptor in epithelial cells (p = 0.018) and subepithelial mesenchymal cells (p = 0.033) and the translocation of glucocorticoid receptor in the nucleus (p = 0.036). Furthermore, bronchial thermoplasty increased the expression of heat shock protein-70 (p = 0.002) and heat shock protein-90 (p = 0.001) in epithelial cells and decreased the expression of heat shock protein-70 (p = 0.009) and heat shock protein-90 (p = 0.002) in subepithelial mesenchymal cells. The effect of bronchial thermoplasty on the expression of heat shock proteins -70 and -90 was distinctive across different asthma endotypes/phenotypes.
CONCLUSIONS CONCLUSIONS
Bronchial thermoplasty leads to a diminishment of airway smooth muscle, to epithelial cell regeneration, increased expression and activation of glucocorticoid receptor in the airways and increased expression of heat shock proteins in the epithelium. Histopathological effects appear to be distinct in different endotypes/phenotypes indicating that the beneficial effects of bronchial thermoplasty are achieved by diverse molecular targets associated with asthma endotypes/phenotypes.

Identifiants

pubmed: 34183014
doi: 10.1186/s12931-021-01774-0
pii: 10.1186/s12931-021-01774-0
pmc: PMC8240300
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

186

Références

Eur J Radiol. 2018 Oct;107:33-38
pubmed: 30292270
Curr Opin Pulm Med. 2008 Jan;14(1):31-8
pubmed: 18043273
Eur Respir J. 2014 Feb;43(2):591-601
pubmed: 23900984
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1452-4
pubmed: 25496106
J Allergy Clin Immunol. 2006 Mar;117(3):549-56
pubmed: 16522452
Am J Respir Crit Care Med. 2019 Feb 15;199(4):536-538
pubmed: 30540915
J Asthma Allergy. 2019 Nov 19;12:375-387
pubmed: 31819539
J Allergy Clin Immunol. 2007 Feb;119(2):336-43
pubmed: 17194469
Eur Respir J. 2019 Dec 4;54(6):
pubmed: 31467116
J Biol Chem. 1994 Feb 18;269(7):5043-9
pubmed: 8106480
J Biol Chem. 1994 Apr 15;269(15):11155-61
pubmed: 8157642
Am Rev Respir Dis. 1993 Jan;147(1):177-81
pubmed: 8420414
Respir Res. 2016 Oct 21;17(1):135
pubmed: 27769261
Clin Exp Allergy. 1998 May;28(5):527-9
pubmed: 9645586
Am J Respir Cell Mol Biol. 1999 Jul;21(1):77-88
pubmed: 10385595
J Allergy Clin Immunol. 2009 Oct;124(4):719-23.e1
pubmed: 19767070
J Vis Exp. 2010 Nov 04;(45):
pubmed: 21189463
Am J Respir Crit Care Med. 2007 Dec 15;176(12):1185-91
pubmed: 17901415
Int J Chron Obstruct Pulmon Dis. 2017 Jan 04;12:177-187
pubmed: 28115841
Biochim Biophys Acta. 2012 Mar;1823(3):730-41
pubmed: 21982864
Chest. 2020 Sep;158(3):923-928
pubmed: 32360725
Ann Am Thorac Soc. 2015 Nov;12(11):1612-8
pubmed: 26325484
J Clin Immunol. 2006 Jul;26(4):376-87
pubmed: 16786432
N Engl J Med. 2004 Aug 5;351(6):560-74
pubmed: 15295049
Crit Care Med. 1994 Jun;22(6):922-9
pubmed: 7794296
Ann Allergy Asthma Immunol. 2013 Nov;111(5):402-7
pubmed: 24125149
Eur Respir J. 2018 May 24;51(5):
pubmed: 29700102
Lung. 2019 Aug;197(4):493-499
pubmed: 31134337
Environ Toxicol. 2019 Apr;34(4):495-504
pubmed: 30600586
J Clin Invest. 2011 Nov;121(11):4348-61
pubmed: 22019588
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
Immunobiology. 2019 Jul;224(4):490-496
pubmed: 31133345
BMC Pulm Med. 2018 Sep 24;18(1):155
pubmed: 30249234
Exp Cell Res. 1996 Feb 25;223(1):163-70
pubmed: 8635489
Eur Respir J. 2019 Jun 5;53(6):
pubmed: 30880282
Ann Allergy Asthma Immunol. 2016 Feb;116(2):92-8
pubmed: 26654482
Am J Respir Crit Care Med. 2010 Jan 15;181(2):116-24
pubmed: 19815809
J Allergy Clin Immunol. 2021 Mar 3;:
pubmed: 33675818
J Allergy Clin Immunol. 2001 Nov;108(5):738-46
pubmed: 11692098
Am J Physiol Lung Cell Mol Physiol. 2020 Aug 1;319(2):L239-L255
pubmed: 32460513
J Allergy Clin Immunol. 2017 Apr;139(4):1176-1185
pubmed: 27609656
Lancet. 2002 Oct 26;360(9342):1293-9
pubmed: 12414205
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1487-94
pubmed: 11704601
Am J Manag Care. 2007 Dec;13(12):661-7
pubmed: 18069909
Eur Respir J. 2011 Sep;38(3):529-37
pubmed: 21310875

Auteurs

Eleni Papakonstantinou (E)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.
Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Triantafyllia Koletsa (T)

Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Liang Zhou (L)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Lei Fang (L)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Michael Roth (M)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Meropi Karakioulaki (M)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Spasenija Savic (S)

Department of Pathology, University Hospital of Basel, Basel, Switzerland.

Leticia Grize (L)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Michael Tamm (M)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland.

Daiana Stolz (D)

Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital of Basel and Department of Biomedicine, University of Basel, Petersgraben 4, 4031, Basel, Switzerland. daiana.stolz@usb.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH